Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Prostate Cancer × Docetaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 415 Carcinoma, Non-Small-Cell Lung 377 Prostatic Neoplasms 250 Lung Neoplasms 147 Stomach Neoplasms 122 Neoplasms 95 Squamous Cell Carcinoma of Head and Neck 94 Neoplasm Metastasis 80 Head and Neck Neoplasms 78 Esophageal Neoplasms 63 Ovarian Neoplasms 48 Urinary Bladder Neoplasms 36 Pancreatic Neoplasms 36 Sarcoma 35 Nasopharyngeal Carcinoma 32 Triple Negative Breast Neoplasms 28 Carcinoma, Squamous Cell 27 Adenocarcinoma of Lung 24 Adenocarcinoma 24 Esophageal Squamous Cell Carcinoma 23 Carcinoma, Ovarian Epithelial 23 Adenocarcinoma Of Esophagus 23 Carcinoma, Transitional Cell 21 Recurrence 20 Breast Neoplasms, Male 19 Parkinson Disease 4, Autosomal Dominant Lewy Body 18 Melanoma 17 Fallopian Tube Neoplasms 17 Carcinoma 16 Unspecified Adult Solid Tumor, Protocol Specific 15

Interventions

Goserelin 2 enzalutamide 1 bicalutamide 1 Radiosurgery 1 Leuprolide 1 Docetaxel 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01224405 2010-10-20

PON-PC-02

University of Turin, Italy

Phase 3 Unknown

Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡